September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.
The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...
July 31, 2019
Castlight Health is seeing some major change ups in leadership this week. Yesterday the digital health company announced that its current CEO John Doyle is stepping down as director. The company has tapped Maeve O’Meara as the company’s next CEO. Siobhan Nolan Mangini will also join as the company’s next president, and maintains her position as chief financial officer.
"With the appointments of...
July 26, 2019
Digital health is still somewhat of an enigma to many in the traditional world of pharma, but that is rapidly changing. As the use cases for digital tools continues to evolve, the life science world is starting to make a concerted effort to engage the new technologies.
This growing digital health ecosystem is now a major conversation point at MassBio, an organization dedicated to advancing the...
July 3, 2019
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.
Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
(Left to right) Nathan Treloar, Sarah Lindenauer and Matteo Lai at the MassBio panel in Cambridge, MA.
May 22, 2019
Virtual assistants and wearable technologies are starting to catch the pharma world’s attention. The industry is exploring how the new tools can be used in research, clinical trials and inpatient settings. However, obstacles including privacy compliance and data standards are still questions that the industry is grappling with, according to panelists at the MassBio forum on Using Clinical Data...
May 21, 2019
This morning Verily announced a series of new strategic partnerships with four global pharmaceutical companies that will bring low-burden digital data collection and analysis tools to clinical research projects.
Alongside Novartis, Otsuka, Pfizer and Sanofi, the Alphabet subsidiary will employ its Project Baseline platform to increase the number and diversity of study populations by making it...
May 6, 2019
The NIH’s All of Us Research Program celebrated its one-year anniversary today with new updates on enrollment progress, previews of its upcoming cloud-based data platform for health researchers and the public beta launch of an online tool for viewing aggregated, de-identified information about the program’s enrollees.
“I hoped [one year ago] that many would share this vision and help us achieve...
March 15, 2019
When it comes to digital health, investors get a bird’s eye view and play a major role in steering the direction of the industry’s future. That is why many are stressing the importance of a diverse viewpoint for investors in an industry focused on bringing digital tools to the masses.
Traditionally this has been a challenge for the venture space, where women only account for 12.2 percent of...
February 25, 2019
Google has been busy recently. Just in the past week it has closed down its Google Fit website, launched a new drug disposal tool and announced the first clinical use of Verily’s machine learning tool for diabetic related diseases.
Below is a look at three of the company’s digital health announcements in the last week.
Addressing the opioid crisis
It started last Wednesday when Google...
February 4, 2019
Verily's prototype smart shoe. Verily is shopping for partners to develop a smart shoe with embedded sensors for movement, weight and fall monitoring, according to a CNBC report citing three anonymous sources. The company allegedly has a prototype design of the footwear that it has been showing off in private meetings, and is envisioning the shoe as a health product.
MRIs are A-OK. Senseonics’...